Sapienza University of Rome

Researchers

• DBDaniele Belvisi

Running trials

• Not yet recruiting

  Perioperative Risk in Patients on Chronic Aspirin Undergoing Craniotomy

  NCT07086183· Mayo Clinic· Source

• Recruiting

  Long Covid (LC)-REVITALIZE - A Long Covid Repurposed Drug Study

  NCT06928272· Phase 3· Douglas D. Fraser· Source

• Recruiting

  Pembrolizumab and Radiotherapy for Oligometastatic Head and Neck Cancer

  NCT05815927· Phase 3· European Organisation for Research and Treatment of Cancer - EORTC· Source

• Recruiting

  Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)

  NCT06819007· Phase 3· Daiichi Sankyo· Source

• Active, not recruiting

  Observational Study of Oral Atogepant to Evaluate Real-World Effectiveness in Adult Participants With Migraine

  NCT06543914· AbbVie· Source

• Recruiting

  Surgical Treatment With or Without Apalutamide in Subjects With High Risk Prostate Cancer Who Are Candidates for Radical Prostatectomy and Staged as Oligometastatic With PSMA-PET

  NCT06758882· Phase 2· Marco Oderda· Source

• Active, not recruiting

  LCH-IV International Collaborative Treatment Protocol for Children and Adolescents with Langerhans Cell Histiocytosis

  NCT02205762· Phase 2/3· St. Anna Childrens Cancer Research Institute GmbH· Source

• Enrolling by invitation

  A Prospective Non-interventional Observational Study to Observe Long-term Treatment and Outcomes in Pulmonary Arterial Hypertension (PAH) Patients

  NCT06445673· AOP Orphan Pharmaceuticals AG· Source

• Recruiting

  Fibrosis Lessens After Metabolic Surgery

  NCT06374875· Phase 4· The Cleveland Clinic· Source

• Recruiting

  Lomustine With and Without Reirradiation for First Progression of Glioblastoma: a Randomized Phase III Study

  NCT05904119· Phase 3· European Organisation for Research and Treatment of Cancer - EORTC· Source

• Active, not recruiting

  Beamion LUNG-2: A Study to Test Whether Zongertinib (BI 1810631) Helps People With Advanced Non-small Cell Lung Cancer With HER2 Mutations Compared With Standard Treatment

  NCT06151574· Phase 3· Boehringer Ingelheim· Source

• Recruiting

  Susceptibility to Infectious Diseases in obEsity: an endocRine trAnslational socioLogic Evaluation, "SIDERALE"

  NCT06236932· Federico II University· Source

• Recruiting

  Initial Triple Therapy Including Parenteral Treprostinil vs Initial Double Oral Therapy in PAH Group I Patients

  NCT06317805· Phase 4· AOP Orphan Pharmaceuticals AG· Source

• Active, not recruiting

  A Real World Effectiveness Study of Pegcetacoplan in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH)

  NCT05776472· Swedish Orphan Biovitrum· Source

• Active, not recruiting

  A CLINICAL TRIAL TO CONFIRM THE EFFICACY OF OLAPARIB IN COMBINATION WITH BEVACIZUMAB, ADMINISTERED AS MAINTENANCE THERAPY AFTER A FRONTLINE PLATINUM BASED CHEMOTHERAPY PLUS BEVACIZUMAB, IN THE TREATMENT OF PATIENTS WITH OVARIAN TUMOURS SHOWING A GENETIC DEFECTS IN A DNA REPAIR MECHANISM CALLED HOMOLOGOUS RECOMBINATION (DEFINED AS HRD POSITIVE, WHERE HRD MEANS HOMOLOGOUS RECOMBINATION DEFICIENCY)

  2022-502242-27-00· Phase 4· Mario Negri Institute For Pharmacological Research· Source

• Recruiting

  Multicentre Clinical Study to Evaluate the Effect of Personalized Therapy on Patients With Immunoglobulin A Nephropathy.

  NCT04662723· Phase 4· Fondazione Schena· Source

• Active, not recruiting

  A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation

  NCT05757869· Phase 3· Janssen Research & Development, LLC· Source

• Recruiting

  "APalutamide and stEReotactic body radiation therapy for low burden metastatic hormone senSItive prostate cancer, a rANdomized trial -PERSIAN".

  2022-501894-37-00· Phase 2· Fondazione Radioterapia Oncologica Onlus· Source

• Active, not recruiting

  Study With Elranatamab Versus Lenalidomide in Patients With Newly Diagnosed Multiple Myeloma After Transplant

  NCT05317416· Phase 3· Pfizer· Source

• Recruiting

  ALTo endogrAft Italian Registry

  NCT05234892· Gianmarco de Donato· Source

• Active, not recruiting

  A Study to Test How Safe Pozelimab and Cemdisiran Combination Therapy and Cemdisiran Alone Are and How Well They Work in Adult Patients With Generalized Myasthenia Gravis

  NCT05070858· Phase 3· Regeneron Pharmaceuticals· Source

• Active, not recruiting

  Extended Access of Momelotinib in Adults With Myelofibrosis

  NCT03441113· Phase 2· GlaxoSmithKline· Source

• Active, not recruiting

  HCMR - Novel Markers of Prognosis in Hypertrophic Cardiomyopathy

  NCT01915615· University of Virginia· Source

• Recruiting

  Celiac Disease Genomic Environmental Microbiome and Metabolomic Study

  NCT02061306· Massachusetts General Hospital· Source

• Recruiting

  Computed Tomography Coronary Angiography (CTCA) Prognostic Registry for Coronary Artery Disease

  NCT01384721· Azienda Ospedaliero-Universitaria di Parma· Source

• Recruiting

  COMPERA / COMPERA-KIDS

  NCT01347216· Technische Universität Dresden· Source

• Recruiting

  Thyroid Function and Structure in Klinefelter Syndrome

  NCT05581147· University of Roma La Sapienza· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• High blood pressure3 recruiting
• Pulmonary arterial hypertension3 recruiting
• Obesity2 recruiting
• Prostate cancer2 recruiting
• Aortic aneurysm1 recruiting
• Brain aneurysm1 recruiting
• Coeliac disease1 recruiting
• Coronary artery disease1 recruiting
• Fatty liver disease (MASLD/MASH)1 recruiting
• Glioblastoma1 recruiting
• Head and neck cancer1 recruiting
• Hypothyroidism1 recruiting
• IgA nephropathy1 recruiting
• Long COVID and ME/CFS1 recruiting
• Ovarian cancer1 recruiting

Closed trials

• Completed

  Microbiota and Lipedema Evaluation in Obese Patient Treated With Very Low Energy Ketogenic Vegan Therapy

  NCT07041684· University of Roma La Sapienza· Source

• Completed

  Early COMT Inhibition in PD

  NCT07917546· Neuromed IRCCS· Source

• Completed

  Personality, Defences, Central Sensitization, and Trauma in Women With Chronic Migraine, Fibromyalgia, and Vulvodynia

  NCT06138171· University of Roma La Sapienza· Source

• Completed

  A Study to Learn About the Safety of BIIB091 and Its Effect on Brain Inflammation When Taken Alone or With Diroximel Fumarate (DRF) in Adults With Relapsing Forms of Multiple Sclerosis (MS)

  NCT05798520· Phase 2· Biogen· Source

• Terminated

  Efficacy, Safety and Tolerability of VS-01 in Adult Patients With Acute-on-Chronic Liver Failure and Ascites (UNVEIL-IT)®

  NCT05900050· Phase 2· Genfit· Source

• Completed

  Lunsayil 1: A Study to Test Whether Spesolimab Helps People With a Skin Disease Called Hidradenitis Suppurativa

  NCT05819398· Phase 2/3· Boehringer Ingelheim· Source

• Completed

  Sleeve Gastrectomy vs. Lifestyle & Medications: Impact on BMI Trajectory and Target Attainment in a Matched Cohort Study

  NCT06820047· University of Roma La Sapienza· Source

• Completed

  A Study of Oral Upadacitinib Tablets to Assess Treatment Patterns, Achievement of Treatment Targets and Maintenance of Response in Adult Participants With Moderate to Severe Rheumatoid Arthritis

  NCT04497597· AbbVie· Source

• Completed

  A Study of JNJ-73763989 + Nucleos(t)Ide Analog in Participants Co-Infected With Hepatitis B and Hepatitis D Virus

  NCT04535544· Phase 2· Janssen Research & Development, LLC· Source

• Recruiting

  Evaluation of Adherence, Persistence and Efficacy of Treatment With PCSK9 Inhibitors in Italy

  NCT05430828· Federico II University· Source

• Completed

  Acalabrutinib Safety Study in Untreated and Relapsed or Refractory Chronic Lymphocytic Leukemia Patients

  NCT04008706· Phase 3· AstraZeneca· Source

• Completed

  Evaluation of the Duration of Effect of Bimatoprost SR in Participants With Open-Angle Glaucoma or Ocular Hypertension

  NCT03850782· Phase 3· AbbVie· Source

• Completed

  Protocol for Muscle Attenuation Cut-offs in Cirrhosis

  NCT06593015· University of Roma La Sapienza· Source

• Completed

  A Study of INCB050465 in Relapsed or Refractory Follicular Lymphoma

  NCT03126019· Phase 2· Incyte Corporation· Source

• Completed

  A Study of INCB050465 in Relapsed or Refractory Mantle Cell Lymphoma Previously Treated With or Without a Bruton's Tyrosine Kinase (BTK) Inhibitor

  NCT03235544· Phase 2· Incyte Corporation· Source

• Completed

  Ponatinib in Participants With Resistant Chronic Phase Chronic Myeloid Leukemia (CP-CML) to Characterize the Efficacy and Safety of a Range of Doses

  NCT02467270· Phase 2· Takeda· Source

• Completed

  LOWER: Lomitapide Observational Worldwide Evaluation Registry

  NCT02135705· Amryt Pharma· Source

• Active, not recruiting

  A Long-term Extension Study of PCI-32765 (Ibrutinib)

  NCT01804686· Phase 3· Janssen Research & Development, LLC· Source

• Completed

  ADVATE/ ADYNOVI Hemophilia A Outcome Database (AHEAD)

  NCT02078427· Baxalta now part of Shire· Source

Conditions

Diseases this institution publishes on or runs trials for.

• Stroke209 works · 0 trials
• Obesity189 works · 4 trials
• Heart failure185 works · 0 trials
• Atrial fibrillation115 works · 1 trial
• Parkinson disease113 works · 1 trial
• Alzheimer disease111 works · 0 trials
• Multiple sclerosis91 works · 1 trial
• Type 2 diabetes84 works · 0 trials
• Migraine80 works · 2 trials
• Coronary artery disease75 works · 1 trial
• Colorectal cancer70 works · 0 trials
• Prostate cancer70 works · 2 trials
• Epilepsy68 works · 0 trials
• Melanoma68 works · 0 trials
• Bladder cancer63 works · 0 trials
• Asthma58 works · 0 trials
• Chronic kidney disease57 works · 0 trials
• Glioblastoma55 works · 1 trial
• Systemic sclerosis (scleroderma)54 works · 0 trials
• Insomnia49 works · 0 trials
• COPD48 works · 0 trials
• Neuroendocrine tumours46 works · 0 trials
• Ovarian cancer41 works · 2 trials
• Osteoarthritis40 works · 0 trials
• Psoriasis40 works · 0 trials
• Schizophrenia37 works · 0 trials
• Pulmonary arterial hypertension35 works · 3 trials
• Amyloidosis33 works · 0 trials
• Crohn's disease31 works · 0 trials
• Fibromyalgia31 works · 1 trial